These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 18189226
1. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Hanley GE, Morgan S, Hurley J, van Doorslaer E. Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226 [Abstract] [Full Text] [Related]
2. The redistributive effect of the move from age-based to income-based prescription drug coverage in British Columbia, Canada. Hanley GE, Morgan S, Barer M, Reid RJ. Health Policy; 2011 Jul; 101(2):185-94. PubMed ID: 21255859 [Abstract] [Full Text] [Related]
3. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Hanley GE, Morgan S. Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288 [Abstract] [Full Text] [Related]
4. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries. Kennedy J, Morgan S. Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719 [Abstract] [Full Text] [Related]
5. An analysis of equity in Brazilian health system financing. Ugá MA, Santos IS. Health Aff (Millwood); 2007 Jan; 26(4):1017-28. PubMed ID: 17630445 [Abstract] [Full Text] [Related]
6. Equity in paying for health care services under a national insurance system. Boaz RF. Milbank Mem Fund Q Health Soc; 1975 Jan; 53(3):337-52. PubMed ID: 808761 [Abstract] [Full Text] [Related]
7. Inequity in publicly funded physician care: what is the role of private prescription drug insurance? Allin S, Hurley J. Health Econ; 2009 Oct; 18(10):1218-32. PubMed ID: 19097042 [Abstract] [Full Text] [Related]
8. Income-based drug coverage in British Columbia: the impact on the distribution of financial burden. Hanley GE, Morgan S, Yan L. Healthc Policy; 2006 Nov; 2(2):e170-86. PubMed ID: 19305698 [Abstract] [Full Text] [Related]
13. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare. Hajizadeh M, Edmonds S. Int J Health Policy Manag; 2020 Mar 01; 9(3):91-95. PubMed ID: 32202091 [Abstract] [Full Text] [Related]
15. Prescription drug accessibility and affordability in the United States and abroad. Morgan S, Kennedy J. Issue Brief (Commonw Fund); 2010 Jun 01; 89():1-12. PubMed ID: 20614652 [Abstract] [Full Text] [Related]
16. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Morgan SG, Agnew JD, Barer ML. Health Policy; 2004 Jun 01; 68(3):299-307. PubMed ID: 15113641 [Abstract] [Full Text] [Related]
18. A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia. Grootendorst P, Stewart D. Health Econ; 2006 Jul 01; 15(7):735-42. PubMed ID: 16498702 [Abstract] [Full Text] [Related]
19. Financing the package of services during the first decade of the national health insurance law in Israel: trends and issues. Shmueli A, Achdut L, Sabag-Endeweld M. Health Policy; 2008 Sep 01; 87(3):273-84. PubMed ID: 18374446 [Abstract] [Full Text] [Related]
20. Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative. Paterson JM, Laupacis A, Bassett K, Anderson GM, BC-Ontario Pharmacosurveillance for Decision-Making Collaborative. Health Aff (Millwood); 2006 Sep 01; 25(5):1436-43. PubMed ID: 16966744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]